Multiple Sclerosis Trial, Recruiting (NCT06957145)

Multiple Sclerosis Trial, Recruiting NCT06957145 Sponsor: Koç University Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06957145 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older who have been diagnosed with Multiple Sclerosis (MS) or a first episode suggestive of MS (called CIS) based on a specific set of recognised diagnostic guidelines (the 2017 McDonald criteria)
People who do not have any other autoimmune disease or cancer at the time of joining
People who have not developed any new autoimmune disease or cancer during the one-year follow-up period of the study
People who have not taken antibiotics, anti-inflammatory pain medicines (such as ibuprofen), or steroid medications within one month before their blood sample is taken
People who have not received any vaccine within one month before their blood sample is taken
People who are not in their menstrual period at the time their blood sample is taken

Who may not be able to join:

People under the age of 18
People who have a current or previous diagnosis of an autoimmune disease or cancer at the time of blood sampling
People who have taken antibiotics, anti-inflammatory pain medicines, or steroids within the month before their blood sample is taken
People who have received a vaccination within the month before their blood sample is taken
People who are in their menstrual period at the time of blood sampling
People who do not have a confirmed MS diagnosis under the 2017 McDonald criteria

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06957145

Sponsor: Koç University

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

More information: https://clinicaltrials.gov/study/NCT06957145

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older who have been diagnosed with Multiple Sclerosis (MS) or a first episode suggestive of MS (called CIS) based on a specific set of recognised diagnostic guidelines (the 2017 McDonald criteria)
People who do not have any other autoimmune disease or cancer at the time of joining
People who have not developed any new autoimmune disease or cancer during the one-year follow-up period of the study
People who have not taken antibiotics, anti-inflammatory pain medicines (such as ibuprofen), or steroid medications within one month before their blood sample is taken
People who have not received any vaccine within one month before their blood sample is taken
People who are not in their menstrual period at the time their blood sample is taken

Who may not be able to join:

People under the age of 18
People who have a current or previous diagnosis of an autoimmune disease or cancer at the time of blood sampling
People who have taken antibiotics, anti-inflammatory pain medicines, or steroids within the month before their blood sample is taken
People who have received a vaccination within the month before their blood sample is taken
People who are in their menstrual period at the time of blood sampling
People who do not have a confirmed MS diagnosis under the 2017 McDonald criteria

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Koç University

Registry

ClinicalTrials.gov

Start date

30 June 2025

Est. completion

30 January 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

VISTA Protein Secretion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov